[{"address1": "1185 Avenue of the Americas", "address2": "Suite 249", "city": "New York", "state": "NY", "zip": "10036", "country": "United States", "phone": "973 242 0005", "website": "https://www.petrospharma.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics in the United States and internationally. It operates through two segments, Prescription Medications and Medical Devices. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a novel and patented topical formulation candidate for the treatment of acute Peyronie's disease. The company offers men's health products, including vacuum erection devices, penile injections, PreBoost, VenoSeal, and urinary tract infection tests for the treatment of erectile dysfunction. Petros Pharmaceuticals, Inc. is based in New York, New York.", "fullTimeEmployees": 21, "companyOfficers": [{"maxAge": 1, "name": "Mr. Fady  Boctor M.B.A.", "age": 45, "title": "President & Chief Commercial Officer", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 681971, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mitchell S. Arnold M.B.A.", "age": 59, "title": "VP of Finance & Chief Accounting Officer", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 465675, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.32, "open": 0.325, "dayLow": 0.32, "dayHigh": 0.439, "regularMarketPreviousClose": 0.32, "regularMarketOpen": 0.325, "regularMarketDayLow": 0.32, "regularMarketDayHigh": 0.439, "beta": 2.309, "forwardPE": -0.38293576, "volume": 1769818, "regularMarketVolume": 1769818, "averageVolume": 164242, "averageVolume10days": 187830, "averageDailyVolume10Day": 187830, "marketCap": 4009828, "fiftyTwoWeekLow": 0.282, "fiftyTwoWeekHigh": 2.27, "priceToSalesTrailing12Months": 0.9730984, "fiftyDayAverage": 0.3439, "twoHundredDayAverage": 0.76127, "currency": "USD", "enterpriseValue": 4471764, "profitMargins": -1.71235, "floatShares": 8991274, "sharesOutstanding": 9606680, "sharesShort": 294901, "sharesShortPriorMonth": 295849, "sharesShortPreviousMonthDate": 1724976000, "dateShortInterest": 1727654400, "sharesPercentSharesOut": 0.0307, "heldPercentInsiders": 0.08443, "heldPercentInstitutions": 0.02161, "shortRatio": 3.85, "shortPercentOfFloat": 0.0361, "impliedSharesOutstanding": 9606680, "bookValue": 0.868, "priceToBook": 0.48087558, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -20644432, "trailingEps": -6.25, "forwardEps": -1.09, "lastSplitFactor": "1:10", "lastSplitDate": 1669852800, "enterpriseToRevenue": 1.085, "enterpriseToEbitda": -0.441, "52WeekChange": -0.7948718, "SandP52WeekChange": 0.39070773, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "PTPI", "underlyingSymbol": "PTPI", "shortName": "Petros Pharmaceuticals, Inc.", "longName": "Petros Pharmaceuticals, Inc.", "firstTradeDateEpochUtc": 1606919400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "a118d857-5b97-3301-9d79-6b7f0a195af0", "messageBoardId": "finmb_429541319", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.4174, "targetHighPrice": 1.0, "targetLowPrice": 1.0, "targetMeanPrice": 1.0, "targetMedianPrice": 1.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 7460014, "totalCashPerShare": 0.777, "ebitda": -10134383, "totalDebt": 7741879, "quickRatio": 0.926, "currentRatio": 1.401, "totalRevenue": 4120681, "debtToEquity": 84.279, "revenuePerShare": 0.99, "returnOnAssets": -0.30613002, "returnOnEquity": -0.63768, "freeCashflow": -4104140, "operatingCashflow": -9103306, "revenueGrowth": -0.287, "grossMargins": 0.7021, "ebitdaMargins": -2.4594, "operatingMargins": -1.60461, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-10-21"}]